Abstract
The effects of the immunosuppressive agents cyclosporin G (CsG) and cyclosporin A (CsA) on collagen arthritis were compared in mice. When administered subcutaneously daily on days 0–13 after immunization with type II collagen, CsG and CsA were both capable of suppressing the development of collagen arthritis in mice as well as the immunological response to native type II collagen in a dose-dependent manner. Histopathologically, no marked inflammatory lesions were observed in diarthroidal joints from mice treated with 100 mg/kg per day of CsA or 800 mg/kg per day of CsG. However, an analysis of dose response showed CsG to be 8 times less potent than CsA in inhibiting the development of arthritis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D. E. Trentham, A. S. Townes and A. H. Kang,Autoimmunity to type II collagen: An experimental model of arthritis. J. Exp. Med.146, 857–868 (1977).
J. S. Courtenay, M. J. Dallman, A. D. Dayan, A. Martin and B. Mosedale,Immunization against heterologous type II collagen induces arthritis in mice. Nature283, 666–668 (1980).
E. S. Cathcart, K. C. Hayes, W. A. Gonnerman, A. A. Lazzari and C. Franzbrau,Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab. Invest.54, 26–31 (1986).
D. E. Trentham,Collagen arthritis as a relevant model for rheumatoid arthritis: Evidence pro and con. Arth. Rheum.25, 911–916 (1982).
J. M. Stuart, M. A. Cremer, A. S. Townes and A. H. Kang,Type II collagen-induced arthritis in rats: Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J. Exp. Med.155, 1–16 (1982).
J. M. Stuart and F. J. Dixon,Serum transfer of collagen-induced arthritis in mice. J. Exp. Med.158, 378–392 (1983).
N. Kaibara, M. Morinaga, C. Arita, T. Hotokebuchi and K. Takagishi,Serum transfer of collagen arthritis in cyclosporin-treated, type II collagen-tolerant rats. Clin. Immunol. Immunopathol.35, 252–260 (1985).
K. Takagishi, N. Kaibara, T. Hotokebuchi, C. Arita, M. Morinaga and K. Arai,Serum transfer of collagen arthritis in congenitally athymic nude rats. J. Immunol.134, 3864–3867 (1985).
M. Dougados, H. Awada and B. Amor,Cyclosporine in rheumatoid arthritis: A double blind placebo controlled study in 52 patients. Ann. Rheum. Dis.47, 127–133 (1988).
M. E. Weinblatt, J. S. Coblyn, P. A. Fraser, R. J. Anderson, J. Spragg, D. E. Trentham and K. R. Austen,Cyclosporin A treatment of refractory rheumatoid arthritis. Arth. Rheum.30, 11–17 (1987).
A. W. A. M. van Rijthoven, B. A. C. Dijkmans, The H. S. Goei, M. Boers and A. Cats,Longterm cyclosporine therapy in rheumatoid arthritis. J. Rheumatol.18, 19–23 (1991).
P. C. Hiestand, H. Gunn, J. Gale, H. Seigl, B. Ryffel, P. Donatsch and J. F. Borel,The immunosuppressive profile of a new natural cyclosporin analogue: Nva 2-C-cyclosporin. Transplant. Proc.17, 1362–1364 (1985).
P. C. Hiestand, H. C. Gunn, J. M. Gale, B. Ryffell and J. F. Borel,Comparison of the pharmacological profiles of cyclosporine, (Nva 2)-cyclosporin and (Val 2)dihydrocyclosporin. Immunology55, 249–255 (1985).
N. Kaibara, T. Hotokebuchi, K. Takagishi and I. Katsuki,Paradoxical effects of cyclosporin A on collagen arthritis in rats. J. Exp. Med.158, 2007–2015 (1983).
F. D. Wood, C. M. Pearson and A. Tanaka,Capacity of myocabacterial Wax D and its subfractions to induce adjuvant arthritis in rats. Int. Arch. Allergy Appl. Immunol.35, 456–467 (1969).
N. Kaibara, T. Hotokebuchi, K. Takagishi, I. Katsuki, C. Morinaga, C. Arita and S. Jingushi,Pathogenetic difference between collagen arthritis and adjuvant arthritis. J. Exp. Med.159, 1388–1396 (1984).
K. Takagishi, N. Kaibara, T. Hotokebuchi, C. Arita, M. Morinaga and K. Arai,Effects of cyclosporin on collagen induced arthritis in mice. Ann. Rheum. Dis.45, 339–344 (1986).
M. A. Cremer, A. D. Hernandez, A. S. Townes, J. M. Stuart and A. H. Kang,Collagen-induced arthritis in rats: Antigenspecific suppression of arthritis and immunity by intravenously injected native type II collagen. J. Immunol.131, 2995–3000 (1983).
K. Takagishi, M. Yamamoto, A. Nishimura, G. Yamasaki, N. Kanazawa, T. Hotokebuchi and N. Kaibara,Effects of Fk-506 on collagen arthritis in mice. Tansplant. Proc.21, 1053–1055 (1989).
B. Ryffel,Pharmacology of cyclosporine VI. Cellular activation: Regulation of intercellular events by cyclosporine. Pharmacol. Rev.41, 407–422 (1989).
E. G. Hoyt, R. C. Hagberg, M. E. Billinggham, J. C. Baldwin and S. W. Jamieson,Analysis of the immunosuppressive and nephrotoxic effects of cyclosporin G. J. Heart Transpl.7, 111–117 (1988).
D. Grant, R. Zhong, C. Stiller, C. Wallace, P. Keown and J. Duff,A comparison of cyclosporine A and Nva 2-cyclosporine (cyclosporine G) in a rat renal allograft model. Transplantation44, 9–12 (1988).
R. B. Nussenblatt, R. R. Caspi, W. J. U. Dinning, A. G. Palestine, P. Hiestand and J. Borel,A comparison of effectiveness of cyclosporine A, D and G in the treatment of experimental autoimmune uveitis in rats. J. Immunopharmacology8, 427–435 (1986).
R. Y. Calne, D. J. D. White, S. Thiru, K. Rolles, S. Drakopoulos and N. V. Jamieson,Cyclosporin G: Immunosupressive effect in dogs with renal allografts. Lancet1, 1342 (1985).
H. Kawashima, M. Mochizuki, K. Okumura, Y. Fujino, T. Tange, D. Horiuchi, E. Higashihara, H. Kaku and G. Inaba,Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat. Jap. J. Ophthalmol.33, 425–440 (1989).
J. R. Jeffery,Cyclosporine analogues. Clin. Biochem.24, 15–21 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takagishi, K., Yamamoto, M., Miyahara, H. et al. Comparative study of effects of cyclosporins A and G on collagen arthritis in mice. Agents and Actions 37, 284–289 (1992). https://doi.org/10.1007/BF02028121
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02028121